Entities / Company
Penumbra.
medical device company in Alameda, California
- Reports this week
- 0
- Active events
- 0
- Connections
- 64
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
Both Penumbra and Koninklijke Philips are identified as large-cap healthcare companies.Some support2 reports
-
Penumbra was acquired by Boston Scientific in a $14.5bn deal, and the company gained clearance for its Thunderbolt product line.Some support2 reports1 development inside
-
A device complementing Lightning Bolt technology has been linked to Penumbra's product line.Some support1 report
-
Penumbra filed reports with the SEC, and Amundi increased its position in Penumbra stock.Some support1 report
-
Penumbra and Diadexus are healthcare companies competing for market share.Some support1 report1 development inside
-
Penumbra and ICU Medical are in the healthcare equipment segment, and their operations intersect with the specialized infrastructure required by Nvidia's chips.Some support1 report
-
Penumbra has been integrated into the unnamed company's strategic plan aimed at recovery in the year 2028.Some support1 report
Gone quiet
No new reports in 90+ days-
Geode Capital Management lifted its stake in Penumbra, while HSBC increased its stake in the company's stock.Some support1 report
-
Penumbra received rating updates on June 17, 2026, as Royal Bank of Canada reaffirmed its sector perform rating and price objective, while Citigroup reduced its price target and set a neutral rating.Some support1 report
-
Analysts reiterated a positive stock rating for Penumbra, reported by MarketBeat.Some support1 report
-
Baron Funds released Q1 2025 investor letter on Penumbra, noting how Trump-era tariffs and onshoring trends affect AI stocks.Some support1 report
-
GlobalData monitors market trends for Penumbra.Speculative1 report
-
Adam Elsesser sold shares worth $4,026,589 of Penumbra in a filing reported on June 30, 2025.Speculative1 report
-
Penumbra, Inc. announced its financial results from its Alameda location.Speculative2 reports
-
ITGR (Integer) has reported a better earnings outlook and lower valuation metrics as of July 11, 2025.Some support1 report
-
Integer and Penumbra are classified as stocks in the Medical - Instruments sector.Some support3 reports
-
Penumbra reported a 22.6% increase in Thrombectomy revenue in July 2025.Some support1 report
-
Penumbra reported that its revenue exceeded the Zacks Consensus Estimate.Some support1 report
-
Penumbra is facing growth impacts due to uncertainties regarding FDA review timelines and revenue decline in China.Some support1 report
-
AMD, Penumbra, Intuitive Surgical, and Integra LifeSciences are noted as peers in the healthcare equipment segment and are involved in generative AI.Some support3 reports
-
Penumbra's stock loss contrasted with S&P 500 gain on August 22, 2025.Some support1 report1 development inside
-
Penumbra, a company in the medical instruments sector, is noted to have underperformed the S&P 500 this year.Some support2 reports
-
Kimball Electronics, PubMatic, and Penumbra were identified as cash-producing businesses as of July 31, 2025.Some support1 report
-
Analysts questioned Penumbra regarding the significance of the STORM-PE study and the rationale for the sales force split.Some support1 report
-
Penumbra is evaluating its differentiated computer-assisted vacuum thrombectomy technology (CAVT) for stroke treatment, gaining traction in the venous setting via the Storm-PE trial.Some support2 reports
-
Penumbra began utilizing Instagram and LinkedIn for company connections on August 21, 2025.Some support2 reports
-
Penumbra promoted Shruthi Narayan to President on August 27, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Penumbra this week
News at the entities that move Penumbra most-
Boston Scientific StructuralBoston Scientific introduced DCBs to the U.S. market on October 21, 2026.Moves Penumbra
-
FDA StructuralWaters Corporation and LabCorp are partnering to expand access to FDA-approved HPV testing options.Moves Penumbra
-
SEC StructuralComcast filed recent holdings with the SEC, while Odyssey's film slate supports the company's momentum.Moves Penumbra
-
Intuitive Surgical OperationalCitigroup and Baird lowered their stock targets for Intuitive Surgical on October 19, 2026.Moves Penumbra
-
Amundi TransactionalAmundi purchased additional shares of Oracle Corporation stock on October 10, 2026.Moves Penumbra
-
Bolt OperationalAnnouncements made on July 11, 2025, included details about Chainlink's updates, a partnership involving Mastercard, Techno's new POVA series, and Bolt/Palantir's Checkout 2.0, all presented at InfoComm 2025.Moves Penumbra
Connections
The 16 strongest of 64, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Boston Scientific Structural
Penumbra is a subsidiary of Boston Scientific following a $14.5bn acquisition completed in June 2026.
-
FDA Structural
The FDA formally regulates Penumbra, requiring product clearances and imposing oversight models for market access.
-
Intuitive Surgical Operational
Penumbra and Intuitive Surgical are active competitors within the medical instruments and healthcare equipment industry.
-
Integer (United States) Operational
The companies are direct competitors in the medical device sector, with evidence comparing their financial outlook and market positioning.
-
SEC Structural
Penumbra is subject to formal regulatory oversight by the SEC, requiring the filing of reports.
-
Amundi Transactional
Amundi increased its investment stake in Penumbra.
-
Bolt Operational
Penumbra's device is functionally complementary to Bolt's technology.
-
LinkedIn Mentioned together
Penumbra utilizes LinkedIn as a platform for professional company connections.
Show all 16 connections
-
MarketBeat Mentioned together
MarketBeat reports on Penumbra's average stock rating.
-
Geode Capital Management Transactional
Geode Capital Management lifted its stake in Penumbra.
-
Colorado Shared context
A is a company whose location is documented as Alameda, California, while B is the state of Colorado.
-
Royal Bank of Canada Mentioned together
The relationship is based on Royal Bank of Canada providing analyst ratings and price targets for Penumbra stock.
-
Instagram Mentioned together
Penumbra utilizes Instagram as a platform for corporate communication and connection.
-
ICU Medical Operational
Both companies are active competitors operating within the specialized healthcare equipment segment.
-
Bac Transactional
Bac handled an acquisition deal that involved Penumbra.
-
Bank of America Mentioned together
The provided evidence does not establish a direct relationship or coupling between Penumbra and Bank of America.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
3 events- Penumbra filed reports with the SEC, and Amundi increased its position in Penumbra stock.
- Penumbra and Diadexus are healthcare companies competing for market share.
- Penumbra and ICU Medical are in the healthcare equipment segment, and their operations intersect with the specialized infrastructure required by Nvidia's chips.
July 2026
2 eventsShow 1 earlier month
June 2026
21 events- A tariff plan caused market tanking on August 22, 2025, impacting publicly traded companies including Golden Entertainment and AbbVie.
- Penumbra was acquired by Boston Scientific in a $14.5bn deal, and the company gained clearance for its Thunderbolt product line.
- Penumbra received rating updates on June 17, 2026, as Royal Bank of Canada reaffirmed its sector perform rating and price objective, while Citigroup reduced its price target and set a neutral rating.
- Analysts reiterated a positive stock rating for Penumbra, reported by MarketBeat.
- Baron Funds released Q1 2025 investor letter on Penumbra, noting how Trump-era tariffs and onshoring trends affect AI stocks.
- GlobalData monitors market trends for Penumbra.
- Adam Elsesser sold shares worth $4,026,589 of Penumbra in a filing reported on June 30, 2025.
- Penumbra, Inc. announced its financial results from its Alameda location.
- ITGR (Integer) has reported a better earnings outlook and lower valuation metrics as of July 11, 2025.
- Integer and Penumbra are classified as stocks in the Medical - Instruments sector.
- Penumbra reported a 22.6% increase in Thrombectomy revenue in July 2025.
- Penumbra reported that its revenue exceeded the Zacks Consensus Estimate.
- Penumbra is facing growth impacts due to uncertainties regarding FDA review timelines and revenue decline in China.
- AMD, Penumbra, Intuitive Surgical, and Integra LifeSciences are noted as peers in the healthcare equipment segment and are involved in generative AI.
- Penumbra's stock loss contrasted with S&P 500 gain on August 22, 2025.
- Penumbra, a company in the medical instruments sector, is noted to have underperformed the S&P 500 this year.
- Kimball Electronics, PubMatic, and Penumbra were identified as cash-producing businesses as of July 31, 2025.
- Analysts questioned Penumbra regarding the significance of the STORM-PE study and the rationale for the sales force split.
- Penumbra is evaluating its differentiated computer-assisted vacuum thrombectomy technology (CAVT) for stroke treatment, gaining traction in the venous setting via the Storm-PE trial.
- Penumbra began utilizing Instagram and LinkedIn for company connections on August 21, 2025.
- Penumbra promoted Shruthi Narayan to President on August 27, 2025.